Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corbus Pharmaceuticals (DE:337)
FRANKFURT:337
RESEARCH TOOLSreports
Corbus Pharmaceuticals (337) Financial Statements
0 Followers
Corbus Pharmaceuticals Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 97.32K |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -8.18M | $ -7.34M | $ -8.52M | $ -10.00M | $ -13.88M |
| EBITDA | $ -7.81M | $ -6.97M | $ -8.15M | $ -9.62M | $ -13.46M |
| Net Income Common Stockholders | $ -8.78M | $ -13.25M | $ -9.44M | $ -10.26M | $ -2.18M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 66.23M | $ 73.30M | $ 86.12M | $ 97.65M | $ 106.86M |
| Total Assets | $ 73.83M | $ 82.07M | $ 95.68M | $ 107.73M | $ 119.57M |
| Total Debt | $ 25.52M | $ 25.74M | $ 26.17M | $ 26.59M | $ 25.90M |
| Net Debt | $ -40.71M | $ -47.57M | $ -59.95M | $ -71.06M | $ -80.96M |
| Total Liabilities | $ 31.88M | $ 32.60M | $ 34.52M | $ 38.62M | $ 41.95M |
| Stockholders Equity | $ 41.95M | $ 49.47M | $ 61.16M | $ 69.11M | $ 77.63M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -7.25M | $ -12.23M | $ -10.63M | $ -9.76M | $ 856.95K |
| Operating Cash Flow | $ -7.25M | $ -12.23M | $ -10.62M | $ -9.70M | $ 856.95K |
| Investing Cash Flow | $ -5.97M | $ -18.70M | $ 42.96M | $ -3.18M | $ 284.10K |
| Financing Cash Flow | $ -110.70K | $ -330.11K | $ -327.13K | $ 767.94K | $ -102.69K |
Corbus Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.